Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies

Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include cancer, diabetes and cardiovascular disease, and has been encouraged for use in the treatment of Alzheimer’s disease (AD), as a result of its complex patholo...

Full description

Saved in:
Bibliographic Details
Published in:Comparative clinical pathology 2023-08, Vol.32 (4), p.699-708
Main Authors: Ekundayo, Bidemi Emmanuel, Obafemi, Tajudeen Olabisi, Adewale, Olusola Bolaji, Oyinloye, Babatunji Emmanuel
Format: Article
Language:English
Subjects:
Alzheimer's disease
Cardiovascular diseases
Clinical trials
Combination therapy
Dementia
Diabetes
Diabetes mellitus
Diabetic neuropathy
Donepezil
Hematology
Medicine
Medicine & Public Health
Memantine
Neurodegenerative diseases
Oncology
Oxidative stress
Pathology
Poisoning
Review Article
Task forces
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943
cites cdi_FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943
container_end_page 708
container_issue 4
container_start_page 699
container_title Comparative clinical pathology
container_volume 32
creator Ekundayo, Bidemi Emmanuel
Obafemi, Tajudeen Olabisi
Adewale, Olusola Bolaji
Oyinloye, Babatunji Emmanuel
description Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include cancer, diabetes and cardiovascular disease, and has been encouraged for use in the treatment of Alzheimer’s disease (AD), as a result of its complex pathological pathways. The combination of memantine and donepezil was approved for use to treat moderate-to-severe AD cases in 2014. Studies have however continued to investigate many other possible combination therapies for the treatment of AD. This article highlights some of the recent combination therapies involving the use of donepezil.
doi_str_mv 10.1007/s00580-023-03487-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2843963564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2843963564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943</originalsourceid><addsrcrecordid>eNp9kLFOwzAQQC0EEqXwA0yRmA1OznGcsSpQkCqxAGKzHPtCU6VxsFNV7cRv8Ht8CSlBgonpbnjvTnqEnMfsMmYsuwqMpZJRlgBlwGVGNwdkFItY0lSkL4d_9mNyEsKSsTiVACPyfO0abHFX1bTQAW1k3KqoGt1Vrom6BXrdbqPS-WhS7xZYrdB_vn-EyFYBezzSjY081rrrzQbX3rW6W1QYTslRqeuAZz9zTJ5ubx6nd3T-MLufTubUJMA3VFppjTUIQliMDc91abjgJU8BpLYgscgKUZTMQMpKbi0YmRSJyAQWuc05jMnFcLf17m2NoVNLt_ZN_1IlkkMuIBV7Khko410IHkvV-mql_VbFTO37qaGf6vup735q00swSKGHm1f0v6f_sb4AqfV23A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2843963564</pqid></control><display><type>article</type><title>Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies</title><source>Springer Nature</source><creator>Ekundayo, Bidemi Emmanuel ; Obafemi, Tajudeen Olabisi ; Adewale, Olusola Bolaji ; Oyinloye, Babatunji Emmanuel</creator><creatorcontrib>Ekundayo, Bidemi Emmanuel ; Obafemi, Tajudeen Olabisi ; Adewale, Olusola Bolaji ; Oyinloye, Babatunji Emmanuel</creatorcontrib><description>Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include cancer, diabetes and cardiovascular disease, and has been encouraged for use in the treatment of Alzheimer’s disease (AD), as a result of its complex pathological pathways. The combination of memantine and donepezil was approved for use to treat moderate-to-severe AD cases in 2014. Studies have however continued to investigate many other possible combination therapies for the treatment of AD. This article highlights some of the recent combination therapies involving the use of donepezil.</description><identifier>ISSN: 1618-565X</identifier><identifier>ISSN: 1618-5641</identifier><identifier>EISSN: 1618-565X</identifier><identifier>DOI: 10.1007/s00580-023-03487-w</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Alzheimer's disease ; Cardiovascular diseases ; Clinical trials ; Combination therapy ; Dementia ; Diabetes ; Diabetes mellitus ; Diabetic neuropathy ; Donepezil ; Hematology ; Medicine ; Medicine &amp; Public Health ; Memantine ; Neurodegenerative diseases ; Oncology ; Oxidative stress ; Pathology ; Poisoning ; Review Article ; Task forces</subject><ispartof>Comparative clinical pathology, 2023-08, Vol.32 (4), p.699-708</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2023. corrected publication 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943</citedby><cites>FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943</cites><orcidid>0000-0002-3078-119X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ekundayo, Bidemi Emmanuel</creatorcontrib><creatorcontrib>Obafemi, Tajudeen Olabisi</creatorcontrib><creatorcontrib>Adewale, Olusola Bolaji</creatorcontrib><creatorcontrib>Oyinloye, Babatunji Emmanuel</creatorcontrib><title>Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies</title><title>Comparative clinical pathology</title><addtitle>Comp Clin Pathol</addtitle><description>Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include cancer, diabetes and cardiovascular disease, and has been encouraged for use in the treatment of Alzheimer’s disease (AD), as a result of its complex pathological pathways. The combination of memantine and donepezil was approved for use to treat moderate-to-severe AD cases in 2014. Studies have however continued to investigate many other possible combination therapies for the treatment of AD. This article highlights some of the recent combination therapies involving the use of donepezil.</description><subject>Alzheimer's disease</subject><subject>Cardiovascular diseases</subject><subject>Clinical trials</subject><subject>Combination therapy</subject><subject>Dementia</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetic neuropathy</subject><subject>Donepezil</subject><subject>Hematology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Memantine</subject><subject>Neurodegenerative diseases</subject><subject>Oncology</subject><subject>Oxidative stress</subject><subject>Pathology</subject><subject>Poisoning</subject><subject>Review Article</subject><subject>Task forces</subject><issn>1618-565X</issn><issn>1618-5641</issn><issn>1618-565X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kLFOwzAQQC0EEqXwA0yRmA1OznGcsSpQkCqxAGKzHPtCU6VxsFNV7cRv8Ht8CSlBgonpbnjvTnqEnMfsMmYsuwqMpZJRlgBlwGVGNwdkFItY0lSkL4d_9mNyEsKSsTiVACPyfO0abHFX1bTQAW1k3KqoGt1Vrom6BXrdbqPS-WhS7xZYrdB_vn-EyFYBezzSjY081rrrzQbX3rW6W1QYTslRqeuAZz9zTJ5ubx6nd3T-MLufTubUJMA3VFppjTUIQliMDc91abjgJU8BpLYgscgKUZTMQMpKbi0YmRSJyAQWuc05jMnFcLf17m2NoVNLt_ZN_1IlkkMuIBV7Khko410IHkvV-mql_VbFTO37qaGf6vup735q00swSKGHm1f0v6f_sb4AqfV23A</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Ekundayo, Bidemi Emmanuel</creator><creator>Obafemi, Tajudeen Olabisi</creator><creator>Adewale, Olusola Bolaji</creator><creator>Oyinloye, Babatunji Emmanuel</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-3078-119X</orcidid></search><sort><creationdate>20230801</creationdate><title>Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies</title><author>Ekundayo, Bidemi Emmanuel ; Obafemi, Tajudeen Olabisi ; Adewale, Olusola Bolaji ; Oyinloye, Babatunji Emmanuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer's disease</topic><topic>Cardiovascular diseases</topic><topic>Clinical trials</topic><topic>Combination therapy</topic><topic>Dementia</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetic neuropathy</topic><topic>Donepezil</topic><topic>Hematology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Memantine</topic><topic>Neurodegenerative diseases</topic><topic>Oncology</topic><topic>Oxidative stress</topic><topic>Pathology</topic><topic>Poisoning</topic><topic>Review Article</topic><topic>Task forces</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ekundayo, Bidemi Emmanuel</creatorcontrib><creatorcontrib>Obafemi, Tajudeen Olabisi</creatorcontrib><creatorcontrib>Adewale, Olusola Bolaji</creatorcontrib><creatorcontrib>Oyinloye, Babatunji Emmanuel</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Comparative clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ekundayo, Bidemi Emmanuel</au><au>Obafemi, Tajudeen Olabisi</au><au>Adewale, Olusola Bolaji</au><au>Oyinloye, Babatunji Emmanuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies</atitle><jtitle>Comparative clinical pathology</jtitle><stitle>Comp Clin Pathol</stitle><date>2023-08-01</date><risdate>2023</risdate><volume>32</volume><issue>4</issue><spage>699</spage><epage>708</epage><pages>699-708</pages><issn>1618-565X</issn><issn>1618-5641</issn><eissn>1618-565X</eissn><abstract>Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include cancer, diabetes and cardiovascular disease, and has been encouraged for use in the treatment of Alzheimer’s disease (AD), as a result of its complex pathological pathways. The combination of memantine and donepezil was approved for use to treat moderate-to-severe AD cases in 2014. Studies have however continued to investigate many other possible combination therapies for the treatment of AD. This article highlights some of the recent combination therapies involving the use of donepezil.</abstract><cop>London</cop><pub>Springer London</pub><doi>10.1007/s00580-023-03487-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3078-119X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1618-565X
ispartof Comparative clinical pathology, 2023-08, Vol.32 (4), p.699-708
issn 1618-565X
1618-5641
1618-565X
language eng
recordid cdi_proquest_journals_2843963564
source Springer Nature
subjects Alzheimer's disease
Cardiovascular diseases
Clinical trials
Combination therapy
Dementia
Diabetes
Diabetes mellitus
Diabetic neuropathy
Donepezil
Hematology
Medicine
Medicine & Public Health
Memantine
Neurodegenerative diseases
Oncology
Oxidative stress
Pathology
Poisoning
Review Article
Task forces
title Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Donepezil-based%20combination%20therapy%20for%20Alzheimer%E2%80%99s%20disease%20and%20related%20neuropathies&rft.jtitle=Comparative%20clinical%20pathology&rft.au=Ekundayo,%20Bidemi%20Emmanuel&rft.date=2023-08-01&rft.volume=32&rft.issue=4&rft.spage=699&rft.epage=708&rft.pages=699-708&rft.issn=1618-565X&rft.eissn=1618-565X&rft_id=info:doi/10.1007/s00580-023-03487-w&rft_dat=%3Cproquest_cross%3E2843963564%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c234w-8d8dcdce366de1c49afc464f45338ad38eb7b6bf0c350f4dd3c82b2676eb9d943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2843963564&rft_id=info:pmid/&rfr_iscdi=true